The Multiplex Association of India has raised alarm over Netflix’s proposed acquisition of Warner Bros. Discovery, warning that the deal could diminish theatrical content availability and threaten ...

Labeling techniques such as immunohistochemistry (IHC) and in situ hybridization (ISH) are long-standing staples for locating proteins, identifying cell types, and pathological diagnostics.

A mechanism underlying neutrophil reprogramming in brain cancers has been uncovered, illuminating potential therapeutic targets to stop their pro-cancer effect. Tumor-infiltrating neutrophils are ...

The cytoskeleton plays a crucial role in regulating cellular behavior, acting as both a structural framework and a mediator of mechanical and biochemical signals that influence cell fate. In the ...

For those hoping to cure death, and they are legion, a 2016 experiment at the Salk Institute for Biological Studies in San Diego has become liminal — the moment that changed everything. The experiment ...

The 2025 Corvette is the subject of a new service bulletin from General Motors, related to a Body Control Module (BCM) problem that causes a check engine light to display. GM is now offering a fix for ...

The completion of the shell and core stage is set for December 2026. Credit: Multiplex. St John’s Wood Square Development has appointed Multiplex to manage the shell and core contract for a ...

Diwas Budhathoki, the dedicated Pokemon aficionado, is your guide into the Pokemon franchise. His eSports writing journey began years ago, and he's been sharing his passion through GameRant since ...

Cellular Origins, a TTP company, acquired the ACTIA (Autologous Cell Therapy Industrial Automation) Platform IP, developed by Geoff Hodge while CEO of SOTIO Biotech US. The ACTIA Platform complements ...

Cellular Origins, a TTP Company, focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), today announced the acquisition of the ACTIA (Autologous ...